With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their ...

Ahead of the market opening on Wednesday, Axis Direct picked five stocks that can generate profits in 5 to 15 days. These are ...

Natco Pharma shares rise 3% as partner Mylan settles U.S. patent litigation with Novo Nordisk for generic Ozempic.

Novo Nordisk (NOV: N) has reached a settlement with Mylan Pharmaceuticals, part of Viatris (Nasdaq: VTRS), concluding a US ...

Nagaraj Shetti, Technical Research Analyst at HDFC Securities, believes Monday's pattern could be considered as a High Wave, ...

IST, the barometer index, the S&P BSE Sensex was up 396.50 points or 0.49% to 81,446.50. The Nifty 50 index added 136.05 points or 0.55% to 24,931.80.

Gilead Sciences collaborates with Indian companies to produce affordable generic versions of its HIV prevention therapy, ...

The Nifty Pharma index closed on a negative note on Monday. Shares of Natco Pharma Ltd.(up 3.53 per cent), Glenmark ...

Godrej Consumer Products shares slipped into the red in the early session on October 8, after the firm said it expects ...

Shares of Tata Power and JSW Energy rose after Nomura initiated coverage, recommending 'buy' ratings with target prices of Rs ...

In view of the Supreme Court's "long conference" on September 30th, it seems timely to review the arguments, pro, con, ...